PipeBio is revolutionizing drug development by offering a no-code, cloud-based SaaS bioinformatics platform that accelerates the creation of therapeutics 10x faster. Their platform integrates configurable sequence and assay-data databases with a robust analytical engine for large NGS datasets, REST API, and intuitive visualization tools. Designed to structure data for machine learning and AI applications, PipeBio empowers the scientific community to optimize the development of antibodies and antibody-like therapeutics.
“No-code bioinformatics is the missing piece with the power to merge two revolutions: in-silico life science, and engineering tools for non-coders. By joining these independent innovation forces, PipeBio is helping enable tomorrow's great biological advancements."
Torsten Kolind, byFounders Collective member